MERCADOLIBRE INC (MELI) Fundamental Analysis & Valuation

NASDAQ:MELI • US58733R1023

Current stock price

1786.01 USD
-53.27 (-2.9%)
Last:

This MELI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. MELI Profitability Analysis

1.1 Basic Checks

  • MELI had positive earnings in the past year.
  • MELI had a positive operating cash flow in the past year.
  • MELI had positive earnings in each of the past 5 years.
  • Each year in the past 5 years MELI had a positive operating cash flow.
MELI Yearly Net Income VS EBIT VS OCF VS FCFMELI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.68%, MELI is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • The Return On Equity of MELI (29.59%) is better than 93.33% of its industry peers.
  • MELI has a better Return On Invested Capital (16.97%) than 90.00% of its industry peers.
  • MELI had an Average Return On Invested Capital over the past 3 years of 21.88%. This is significantly above the industry average of 8.83%.
  • The 3 year average ROIC (21.88%) for MELI is well above the current ROIC(16.97%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.68%
ROE 29.59%
ROIC 16.97%
ROA(3y)5.96%
ROA(5y)4.44%
ROE(3y)35.22%
ROE(5y)27.5%
ROIC(3y)21.88%
ROIC(5y)17.77%
MELI Yearly ROA, ROE, ROICMELI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30 40

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.91%, MELI is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
  • In the last couple of years the Profit Margin of MELI has grown nicely.
  • MELI has a Operating Margin of 11.08%. This is in the better half of the industry: MELI outperforms 80.00% of its industry peers.
  • MELI's Operating Margin has improved in the last couple of years.
  • MELI has a Gross Margin (44.50%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of MELI has remained more or less at the same level.
Industry RankSector Rank
OM 11.08%
PM (TTM) 6.91%
GM 44.5%
OM growth 3Y3.76%
OM growth 5Y28.09%
PM growth 3Y15.63%
PM growth 5YN/A
GM growth 3Y-2.64%
GM growth 5Y0.68%
MELI Yearly Profit, Operating, Gross MarginsMELI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MELI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MELI is creating value.
  • MELI has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MELI has been increased compared to 5 years ago.
  • The debt/assets ratio for MELI has been reduced compared to a year ago.
MELI Yearly Shares OutstandingMELI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
MELI Yearly Total Debt VS Total AssetsMELI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 2.81 indicates that MELI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.81, MELI is in line with its industry, outperforming 56.67% of the companies in the same industry.
  • MELI has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.85, MELI is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • MELI has a Debt/Equity ratio of 0.68. This is a neutral value indicating MELI is somewhat dependend on debt financing.
  • The Debt to Equity ratio of MELI (0.68) is worse than 63.33% of its industry peers.
  • Although MELI's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 0.85
Altman-Z 2.81
ROIC/WACC1.85
WACC9.17%
MELI Yearly LT Debt VS Equity VS FCFMELI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.17 indicates that MELI should not have too much problems paying its short term obligations.
  • The Current ratio of MELI (1.17) is worse than 73.33% of its industry peers.
  • A Quick Ratio of 1.15 indicates that MELI should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.15, MELI is in line with its industry, outperforming 46.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.15
MELI Yearly Current Assets VS Current LiabilitesMELI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. MELI Growth Analysis

3.1 Past

  • MELI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.51%.
  • MELI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 60.44% yearly.
  • MELI shows a strong growth in Revenue. In the last year, the Revenue has grown by 39.06%.
  • The Revenue has been growing by 48.70% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4.51%
EPS 3Y60.44%
EPS 5YN/A
EPS Q2Q%-12.53%
Revenue 1Y (TTM)39.06%
Revenue growth 3Y38.91%
Revenue growth 5Y48.7%
Sales Q2Q%44.56%

3.2 Future

  • MELI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.40% yearly.
  • Based on estimates for the next years, MELI will show a very strong growth in Revenue. The Revenue will grow by 23.62% on average per year.
EPS Next Y35.36%
EPS Next 2Y36.63%
EPS Next 3Y37.07%
EPS Next 5Y36.4%
Revenue Next Year34.82%
Revenue Next 2Y29.4%
Revenue Next 3Y25.73%
Revenue Next 5Y23.62%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MELI Yearly Revenue VS EstimatesMELI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B 100B
MELI Yearly EPS VS EstimatesMELI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 100 200 300

More info and screens

Find the best growth stocksShow best growing peers

4

4. MELI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 45.33, which means the current valuation is very expensive for MELI.
  • MELI's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.15. MELI is valued rather expensively when compared to this.
  • MELI is valuated quite expensively with a Price/Forward Earnings ratio of 33.49.
  • Based on the Price/Forward Earnings ratio, MELI is valued a bit more expensive than 66.67% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of MELI to the average of the S&P500 Index (22.12), we can say MELI is valued expensively.
Industry RankSector Rank
PE 45.33
Fwd PE 33.49
MELI Price Earnings VS Forward Price EarningsMELI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MELI is on the same level as its industry peers.
  • 83.33% of the companies in the same industry are more expensive than MELI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.41
EV/EBITDA 23.27
MELI Per share dataMELI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of MELI may justify a higher PE ratio.
  • A more expensive valuation may be justified as MELI's earnings are expected to grow with 37.07% in the coming years.
PEG (NY)1.28
PEG (5Y)N/A
EPS Next 2Y36.63%
EPS Next 3Y37.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MELI Dividend Analysis

5.1 Amount

  • MELI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MELI Fundamentals: All Metrics, Ratios and Statistics

MERCADOLIBRE INC

NASDAQ:MELI (4/28/2026, 11:42:21 AM)

1786.01

-53.27 (-2.9%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)02-24
Earnings (Next)05-07
Inst Owners82.77%
Inst Owner Change-0.1%
Ins Owners0.26%
Ins Owner Change0%
Market Cap90.55B
Revenue(TTM)28.89B
Net Income(TTM)2.00B
Analysts83.87
Price Target2564.08 (43.56%)
Short Float %2.18%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.17%
Min EPS beat(2)-12.64%
Max EPS beat(2)-5.7%
EPS beat(4)1
Avg EPS beat(4)-4.66%
Min EPS beat(4)-15.3%
Max EPS beat(4)14.99%
EPS beat(8)4
Avg EPS beat(8)5.59%
EPS beat(12)7
Avg EPS beat(12)3.94%
EPS beat(16)10
Avg EPS beat(16)6.86%
Revenue beat(2)2
Avg Revenue beat(2)1.02%
Min Revenue beat(2)0.61%
Max Revenue beat(2)1.44%
Revenue beat(4)3
Avg Revenue beat(4)1.88%
Min Revenue beat(4)-0.1%
Max Revenue beat(4)5.59%
Revenue beat(8)6
Avg Revenue beat(8)3%
Revenue beat(12)10
Avg Revenue beat(12)2.83%
Revenue beat(16)13
Avg Revenue beat(16)3.26%
PT rev (1m)-10.17%
PT rev (3m)-10.44%
EPS NQ rev (1m)-6.48%
EPS NQ rev (3m)-18.76%
EPS NY rev (1m)-8.86%
EPS NY rev (3m)-13.56%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)5.23%
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)4.73%
Valuation
Industry RankSector Rank
PE 45.33
Fwd PE 33.49
P/S 3.13
P/FCF 8.41
P/OCF 7.47
P/B 13.42
P/tB 13.82
EV/EBITDA 23.27
EPS(TTM)39.4
EY2.21%
EPS(NY)53.33
Fwd EY2.99%
FCF(TTM)212.49
FCFY11.9%
OCF(TTM)238.97
OCFY13.38%
SpS569.88
BVpS133.1
TBVpS129.23
PEG (NY)1.28
PEG (5Y)N/A
Graham Number343.497 (-80.77%)
Profitability
Industry RankSector Rank
ROA 4.68%
ROE 29.59%
ROCE 22.81%
ROIC 16.97%
ROICexc 30.8%
ROICexgc 31.6%
OM 11.08%
PM (TTM) 6.91%
GM 44.5%
FCFM 37.29%
ROA(3y)5.96%
ROA(5y)4.44%
ROE(3y)35.22%
ROE(5y)27.5%
ROIC(3y)21.88%
ROIC(5y)17.77%
ROICexc(3y)229.5%
ROICexc(5y)162.58%
ROICexgc(3y)538.3%
ROICexgc(5y)354.16%
ROCE(3y)29.4%
ROCE(5y)23.88%
ROICexgc growth 3Y-33.3%
ROICexgc growth 5YN/A
ROICexc growth 3Y-28.99%
ROICexc growth 5YN/A
OM growth 3Y3.76%
OM growth 5Y28.09%
PM growth 3Y15.63%
PM growth 5YN/A
GM growth 3Y-2.64%
GM growth 5Y0.68%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 0.85
Debt/EBITDA 1.14
Cap/Depr 164.18%
Cap/Sales 4.65%
Interest Coverage 5.24
Cash Conversion 301.47%
Profit Quality 539.46%
Current Ratio 1.17
Quick Ratio 1.15
Altman-Z 2.81
F-Score5
WACC9.17%
ROIC/WACC1.85
Cap/Depr(3y)133.57%
Cap/Depr(5y)162.49%
Cap/Sales(3y)4.05%
Cap/Sales(5y)5%
Profit Quality(3y)459.33%
Profit Quality(5y)464.07%
High Growth Momentum
Growth
EPS 1Y (TTM)4.51%
EPS 3Y60.44%
EPS 5YN/A
EPS Q2Q%-12.53%
EPS Next Y35.36%
EPS Next 2Y36.63%
EPS Next 3Y37.07%
EPS Next 5Y36.4%
Revenue 1Y (TTM)39.06%
Revenue growth 3Y38.91%
Revenue growth 5Y48.7%
Sales Q2Q%44.56%
Revenue Next Year34.82%
Revenue Next 2Y29.4%
Revenue Next 3Y25.73%
Revenue Next 5Y23.62%
EBIT growth 1Y21.66%
EBIT growth 3Y44.14%
EBIT growth 5Y90.47%
EBIT Next Year54.93%
EBIT Next 3Y39.18%
EBIT Next 5Y36.51%
FCF growth 1Y52.64%
FCF growth 3Y63.06%
FCF growth 5Y63.03%
OCF growth 1Y53.02%
OCF growth 3Y60.33%
OCF growth 5Y59.26%

MERCADOLIBRE INC / MELI Fundamental Analysis FAQ

What is the fundamental rating for MELI stock?

ChartMill assigns a fundamental rating of 6 / 10 to MELI.


What is the valuation status for MELI stock?

ChartMill assigns a valuation rating of 4 / 10 to MERCADOLIBRE INC (MELI). This can be considered as Fairly Valued.


How profitable is MERCADOLIBRE INC (MELI) stock?

MERCADOLIBRE INC (MELI) has a profitability rating of 8 / 10.


How financially healthy is MERCADOLIBRE INC?

The financial health rating of MERCADOLIBRE INC (MELI) is 5 / 10.


What is the earnings growth outlook for MERCADOLIBRE INC?

The Earnings per Share (EPS) of MERCADOLIBRE INC (MELI) is expected to grow by 35.36% in the next year.